Rudolf A Kley1, Montse Olivé, Rolf Schröder. 1. aDepartment of Neurology, Heimer Institute for Muscle Research, University Hospital Bergmannsheil, Ruhr-University Bochum, Bochum, Germany bInstitute of Neuropathology, Department of Pathology and Neuromuscular Unit, IDIBELL-Hospital Universitari de Bellvitge, Barcelona, Spain cInstitute of Neuropathology, University Hospital Erlangen, Erlangen, Germany.
Abstract
PURPOSE OF REVIEW: Myofibrillar myopathies (MFMs) are hereditary muscle disorders characterized by distinct histopathological features. This review provides an overview of recent research with respect to new disease genes, clinical phenotypes, insights into pathomechanisms and therapeutic strategies. RECENT FINDINGS: Beyond the known disease genes DES, FLNC, MYOT, CRYAB, ZASP, BAG3, FHL1 and TTN, mutations in PLEC, ACTA1, HSPB8 and DNAJB6 have also been associated with a MFM phenotype. Proteomic analysis revealed new information about the composition of protein aggregates in myotilinopathy and identified a new diagnostic marker. New animal models mirror central aspects of MFM pathology and novel therapeutic strategies for treatment of MFM were evaluated in cell and animal models. SUMMARY: MFMs are an expanding and numerically significant group of protein aggregate diseases with marked clinical and genetic heterogeneity. Though no specific therapy is currently available, the generation of patient-mimicking cell and animal models now paves the way for the preclinical evaluation of novel therapeutic strategies.
PURPOSE OF REVIEW: Myofibrillar myopathies (MFMs) are hereditary muscle disorders characterized by distinct histopathological features. This review provides an overview of recent research with respect to new disease genes, clinical phenotypes, insights into pathomechanisms and therapeutic strategies. RECENT FINDINGS: Beyond the known disease genes DES, FLNC, MYOT, CRYAB, ZASP, BAG3, FHL1 and TTN, mutations in PLEC, ACTA1, HSPB8 and DNAJB6 have also been associated with a MFM phenotype. Proteomic analysis revealed new information about the composition of protein aggregates in myotilinopathy and identified a new diagnostic marker. New animal models mirror central aspects of MFM pathology and novel therapeutic strategies for treatment of MFM were evaluated in cell and animal models. SUMMARY: MFMs are an expanding and numerically significant group of protein aggregate diseases with marked clinical and genetic heterogeneity. Though no specific therapy is currently available, the generation of patient-mimicking cell and animal models now paves the way for the preclinical evaluation of novel therapeutic strategies.
Authors: Xiaojing Sui; Douglas E V Pires; Angelique R Ormsby; Dezerae Cox; Shuai Nie; Giulia Vecchi; Michele Vendruscolo; David B Ascher; Gavin E Reid; Danny M Hatters Journal: Proc Natl Acad Sci U S A Date: 2020-01-21 Impact factor: 11.205
Authors: Darren M Hutt; Sanjay Kumar Mishra; Daniela Martino Roth; Mads Breum Larsen; Frédéric Angles; Raymond A Frizzell; William E Balch Journal: J Biol Chem Date: 2018-07-09 Impact factor: 5.157
Authors: Julia Schuld; Peter F M van der Ven; Anne Schänzer; Elisabeth Schumann; Diana Zengeler; Lisann Gulatz; Giovanni Maroli; Uwe Ahting; Anke Sprengel; Sabine Gräf; Andreas Hahn; Christian Jux; Till Acker; Dieter O Fürst; Stefan Rupp Journal: J Muscle Res Cell Motil Date: 2021-03-12 Impact factor: 2.698
Authors: Rocio Bengoechea; Andrew R Findlay; Ankan K Bhadra; Hao Shao; Kevin C Stein; Sara K Pittman; Jil Aw Daw; Jason E Gestwicki; Heather L True; Conrad C Weihl Journal: J Clin Invest Date: 2020-08-03 Impact factor: 19.456
Authors: Jakub P Fichna; Anna Potulska-Chromik; Przemysław Miszta; Maria Jolanta Redowicz; Anna M Kaminska; Cezary Zekanowski; Sławomir Filipek Journal: BBA Clin Date: 2016-11-11
Authors: Andreas Unger; Lisa Beckendorf; Pierre Böhme; Rudolf Kley; Marion von Frieling-Salewsky; Hanns Lochmüller; Rolf Schröder; Dieter O Fürst; Matthias Vorgerd; Wolfgang A Linke Journal: Acta Neuropathol Commun Date: 2017-09-15 Impact factor: 7.801
Authors: Delphine Bouhy; Manisha Juneja; Istvan Katona; Anne Holmgren; Bob Asselbergh; Vicky De Winter; Tino Hochepied; Steven Goossens; Jody J Haigh; Claude Libert; Chantal Ceuterick-de Groote; Joy Irobi; Joachim Weis; Vincent Timmerman Journal: Acta Neuropathol Date: 2017-08-05 Impact factor: 17.088
Authors: Rudolf Andre Kley; Yvonne Leber; Bertold Schrank; Heidi Zhuge; Zacharias Orfanos; Julius Kostan; Adekunle Onipe; Dominik Sellung; Anne Katrin Güttsches; Britta Eggers; Frank Jacobsen; Wolfram Kress; Katrin Marcus; Kristina Djinovic-Carugo; Peter F M van der Ven; Dieter O Fürst; Matthias Vorgerd Journal: Neurol Genet Date: 2021-05-18